Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AMLAndreas T. Björklund, Karl‐Johan Malmberg, Pontus Blomberg et al.|Clinical Cancer Research|2018Cited by 195
Naive Donor NK Cell Repertoires Associated with Less Leukemia Relapse after Allogeneic Hematopoietic Stem Cell TransplantationAndreas T. Björklund, Karl‐Johan Malmberg, Trevor Clancy et al.|The Journal of Immunology|2016Cited by 36
Supplementary Data from Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AMLAndreas T. Björklund, Karl‐Johan Malmberg, Mattias Carlsten et al.|Unknown|2023Cited by 0
Data from Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AMLAndreas T. Björklund, Karl‐Johan Malmberg, Mattias Carlsten et al.|Unknown|2023Cited by 0
Data from Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AMLAndreas T. Björklund, Karl‐Johan Malmberg, Mattias Carlsten et al.|Unknown|2023Cited by 0